Alerts
Blog Entries - Mar. 2022
2023
October
September
August
July
May
January
2022
December
November
August
July
June
May
April
March
2021
December
November
October
September
August
July
June
May
April
March
February
January
2020
December
November
October
September
August
July
June
May
April
March
February
January
2019
December
November
October
September
August
July
June
May
April
March
February
January
2018
December
November
October
September
August
July
June
May
April
March
February
January
2017
December
November
October
September
August
July
June
May
April
March
February
January
2016
December
November
October
September
August
July
June
May
April
March
February
January
2015
December
November
October
September
August
July
June
May
April
March
February
January
2014
December
November
October
September
August
July
June
May
April
March
February
January
2013
December
- 2023
- October
- September
- August
- July
- May
- January
- 2022
- December
- November
- August
- July
- June
- May
- April
- March
- 2021
- December
- November
- October
- September
- August
- July
- June
- May
- April
- March
- February
- January
- 2020
- December
- November
- October
- September
- August
- July
- June
- May
- April
- March
- February
- January
- 2019
- December
- November
- October
- September
- August
- July
- June
- May
- April
- March
- February
- January
- 2018
- December
- November
- October
- September
- August
- July
- June
- May
- April
- March
- February
- January
- 2017
- December
- November
- October
- September
- August
- July
- June
- May
- April
- March
- February
- January
- 2016
- December
- November
- October
- September
- August
- July
- June
- May
- April
- March
- February
- January
- 2015
- December
- November
- October
- September
- August
- July
- June
- May
- April
- March
- February
- January
- 2014
- December
- November
- October
- September
- August
- July
- June
- May
- April
- March
- February
- January
- 2013
- December
Adamis Pharmaceuticals Corporation Issues Nationwide Voluntary Recall of SYMJEPI® (Epinephrine) Injection for Potential
March 23, 2022
San Diego, March 21, 2022 – Adamis Pharmaceuticals Corporation (Nasdaq: ADMP) is voluntarily recalling certain lots of SYMJEPI (epinephrine) Injection 0.15 mg (0.15 mg/0.3 mL) and 0.3 mg (0.3 mg/0.3 mL) Pre-Filled